COMPANY OVERVIEW

CBT Pharmaceuticals is a biopharmaceutical company focused on developing innovative oncology therapeutics harnessing the immune system and targeting specific molecular pathways to tame cancer.

---

LOCATION

Pleasanton, CA, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.cbtpharma.com/

---

CAREER WEBSITE

https://www.cbtpharma.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jan 7, 2019

Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing

Dec 10, 2018

CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors

Dec 10, 2018

CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors

Nov 26, 2018

CBT Pharmaceuticals and Zhejiang Bossan Pharmaceutical Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments

Sep 18, 2018

CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program

For More Press Releases

---